Reply To: PPE for MTX administration to non-oncology patients

  • Kimberly Duback

    Member
    May 23, 2018 at 10:12 pm

    We are currently putting together education to be disseminated to all nurses in the system on PPE, our closed system transfer device (CSTD) and protection from hazardous medications.  Currently, we do have a system hazardous medication policy that outlines PPE use for all hazardous medications (included is all doses of MTX) and all of our hazardous medications do have a label that indicates hazard and which PPE may be included (however, I cannot validate the compliance with hazardous medication PPE outside of oncology)

    As an aside, we are only utilizing our Closed System Transfer Device (OnGuard- BBraun)  for hazardous oncology meds since the non-oncology nurses have not received the education; however, after the education is given to all nurses, the CSTD use will expand to hazardous medications provided even outside the oncology patients.

    ——————————
    Kimberly Duback, MS, APN, PCNS-BC, CPN, CPHON
    Advanced Practice Nurse
    Advocate Children’s Hospital
    Illinois
    United States of America
    ——————————
    ——————————————-
    Original Message:
    Sent: 05-23-2018 02:48 PM
    From: Dina Smith Schnurman
    Subject: PPE for MTX administration to non-oncology patients

    ​Does your institution require nurses to wear PPE for administration of MTX to rheumatology patients? We have this set as our standard but are receiving push back from rheumatology because it is a low dose of MTX. The MTX is not always available in the injection pens, so they are requesting nursing teach families how to draw up MTX from a vial- not under a hood, and without PPE. Would like some feedback from other institutions who administer MTX to rheumatology patients.

    ——————————
    Dina Smith Schnurman, CPON,MBA,MSN,RN
    Sidra Medicine
    Doha, Qatar
    ——————————